Testosterone
Test · T · Test E (enanthate) · Test C (cypionate) · Test P (propionate) · Testosterone Undecanoate · Sustanon 250 · Testosterone Suspension
Last updated
At a glance
100
Testosterone = 100
100
Testosterone = 100
Overview
Testosterone is the compound every other anabolic is measured against — literally. Its anabolic:androgenic ratio of 100:100 is the reference point the entire AAS landscape is indexed to, and for good reason: supraphysiologic T reliably adds lean mass, strength, recovery, libido, and confidence in a way nothing else quite replicates. It's the base of virtually every serious physique protocol, the first cycle almost everyone should run, and the floor that keeps 19-nors and DHT-derivatives from wrecking sexual function.
The dose-response is clean and well-characterized. Bhasin's landmark trials showed lean mass and strength scaling roughly log-linearly with dose across physiologic and supraphysiologic ranges — and those gains happened even in sedentary subjects, meaning T is doing real anabolic work before training ever enters the equation.
"Fat-free mass, muscle size, and strength increased significantly only in those groups that received testosterone; the changes were dose dependent." — Bhasin et al., NEJM 1996
For bodybuilders and looksmaxxers, the practical appeal is that T is predictable, forgiving, and well-studied. Side effects — hematocrit creep, estrogen management, HPTA shutdown — are manageable with bloodwork, an AI dosed to symptoms, and a structured PCT. Modern community practice (twice-weekly SC injection, sensitive E2 assays, HCG on cycle) has made a T-only cycle one of the cleanest-running protocols in the sport.
In this guide we'll cover the ester landscape (prop vs enanthate vs cypionate vs undecanoate), first-cycle dosing, TRT versus blast ranges, SC vs IM injection technique, estrogen and hematocrit management, full PCT protocols, stacking logic, and the common mistakes — crushed E2, skipped HCG, ignored blood pressure — that turn an otherwise textbook cycle into a mess.
How Testosterone works
Androgen Receptor Activation#
Testosterone is the prototypical androgen receptor (AR) agonist and the reference compound every other AAS is benchmarked against (anabolic:androgenic rating of 100:100 by definition). Free T diffuses across the cell membrane, binds cytoplasmic AR, and the ligand-receptor complex translocates to the nucleus where it docks onto androgen response elements (AREs) in DNA. This drives transcription of genes governing myofibrillar protein synthesis, satellite cell activation, and erythropoiesis.
The practical payoff: T increases muscle protein synthesis and decreases protein breakdown, while simultaneously recruiting new myonuclei via satellite cell fusion. Those extra nuclei are what make gains "stick" — a biological basis for the muscle memory every experienced user has felt firsthand.
"Fat-free mass, muscle size, and strength increased significantly only in those groups that received testosterone; the changes were dose dependent." — Bhasin S et al., The New England Journal of Medicine, 1996
Notably, the 1996 trial showed that 600 mg/week added fat-free mass in sedentary men who didn't train at all. Testosterone works on the receptor whether you earn it or not — training just compounds the effect.
5α-Reduction to DHT#
In tissues rich in 5α-reductase (skin, scalp, prostate, genitals, CNS), testosterone converts to dihydrotestosterone (DHT) — an AR agonist with roughly 3–10× the binding affinity of T itself. DHT is why a T cycle feels different from a non-aromatizing compound: libido spikes, aggression sharpens, facial hair thickens, skin gets oilier.
The downside is the same mechanism: DHT drives androgenic alopecia in genetically predisposed men, acne, and prostate hypertrophy. This is the rationale for topical AR antagonists (RU58841, pyrilutamide) on the scalp during cycles — blocking the receptor locally without nuking systemic DHT the way oral finasteride does. Oral finasteride works but blunts some of the libido and wellbeing benefits of the cycle, which is why topical is the community preference for anyone running AAS.
Aromatization to Estradiol#
CYP19 aromatase in adipose tissue, liver, brain, and bone converts a fraction of circulating T into 17β-estradiol (E2). This is not a side effect to eliminate — E2 is essential for libido, erectile function, joint lubrication, favourable lipids, bone density, and the full IGF-1 response to T.
The most common self-inflicted wound on cycle is crushing E2 with aggressive anastrozole dosing chasing phantom gyno. Tanked E2 means dead libido, flat mood, achy joints, and wrecked lipids — a worse outcome than slightly elevated E2. Dose AI to labs and symptoms, never prophylactically. When gyno or water retention is genuinely the problem, 0.25–0.5 mg anastrozole E3D is almost always sufficient.
Direct Anabolic and Anti-Catabolic Signalling#
Beyond genomic AR transcription, T exerts non-genomic effects through membrane-associated AR and mTOR pathway activation, and blunts glucocorticoid receptor signalling — partially displacing cortisol from its receptor. The net effect: more synthesis, less breakdown, faster recovery between sessions. This is why work capacity jumps noticeably within the first 3–4 weeks of a cycle, well before esters have even reached steady-state, and why recovery between heavy sessions collapses from 72 hours to 24–36.
"Changes in fat-free mass, muscle size, and strength were dependent on the administered testosterone dose, with few adverse events reported within the range studied." — Bhasin S et al., American Journal of Physiology. Endocrinology and Metabolism, 2001
The dose-response is roughly log-linear through ~600 mg/week in trained men — above that, E2 and hematocrit costs rise faster than the marginal FFM benefit, which is why most experienced users settle at 400–500 mg/week T and add a second compound rather than pushing T higher.
Erythropoiesis and Oxygen Delivery#
T directly stimulates renal EPO production and suppresses hepcidin, increasing red blood cell mass and hematocrit. The endurance and pump benefits are real — more oxygen delivery, better work capacity, denser vascularity. The cost is a predictable rise in HCT toward or past 54%, at which point blood viscosity raises thrombotic risk meaningfully.
This is the single most monitorable risk of a T cycle. Check HCT every 8–12 weeks; donate blood or get a therapeutic phlebotomy if it creeps high. Twice-weekly SC injection produces flatter peaks and lower HCT than once-weekly IM with the same total dose — one of the cleanest "free wins" in protocol design.
"Serum testosterone concentrations were similar, and subcutaneous administration was well tolerated and preferred by the majority of subjects." — Spratt DI et al., The Journal of Clinical Endocrinology & Metabolism, 2017
HPTA Suppression#
Exogenous T suppresses hypothalamic GnRH release, which shuts down pituitary LH and FSH, which in turn shuts down endogenous testicular T production and spermatogenesis. Expect complete shutdown within 2–4 weeks of any supraphysiologic dose. This is not a side effect — it's the system working exactly as designed, and it's why PCT exists.
HCG (250–500 IU twice weekly) mimics LH directly at the Leydig cell, keeping testicular volume and intratesticular T intact through the cycle and making post-cycle restart dramatically cleaner. Skip HCG on a long blast and you're looking at months of sluggish recovery even with a textbook SERM PCT — a trade every experienced user eventually learns to avoid.
Protocol
| Level | Dose | Frequency | Notes |
|---|---|---|---|
| Low | 300–500 mg | Twice weekly | Documented entry-level range |
| Mid | 500–750 mg | Twice weekly | Most commonly studied range |
| High | 750–1000 mg | Twice weekly | For enanthate/cypionate, split weekly dose into Mon/Thu injections SC (insulin pin, lower belly) or IM (ventroglute/delt). Propionate runs EOD or E3D. Undecanoate q10–14 weeks. Once-weekly dosing produces uncomfortable E2 peaks/troughs — twice weekly is the community standard. |
Cycle length & outcomes
Documented cycle
12–16 weeks
Plateau after
16 wks
Cycle Length & Structure#
Testosterone cycles are built around ester kinetics and the reality that HPTA suppression is complete within 2–4 weeks of any supraphysiologic dose. Unlike peptides, you can't just "stop when you're done" — the back end of every cycle is a structured recovery, not an afterthought.
The community standard for a first cycle is 16 weeks of test enanthate or cypionate at 400–500 mg/week, split twice weekly. Shorter than 12 weeks and you're barely past the point where long esters have fully saturated; longer than 16 and you're accumulating HCT, lipid, and BP debt faster than you're adding FFM.
Dose Ladder by Goal#
| Goal | Ester | Cycle Length | Weekly Dose | Frequency |
|---|---|---|---|---|
| First cycle (T-only) | Enanthate / Cypionate | 14–16 weeks | 400–500 mg | Mon/Thu SC or IM |
| Lean bulk / recomp base | Enanthate / Cypionate | 12–16 weeks | 300–400 mg | Twice weekly |
| Intermediate blast | Enanthate / Cypionate | 12–16 weeks | 500–750 mg | Twice weekly |
| Contest prep (T as base) | Propionate or Enanthate | 10–12 weeks | 150–250 mg | E3D (prop) / 2×wk (enan) |
| Year-round cruise | Enanthate / Cypionate | Indefinite | 150–250 mg | Twice weekly SC |
| Advanced blast (T as anti-shutdown base) | Enanthate / Cypionate | 12–16 weeks | 200–400 mg | Twice weekly |
Above ~600 mg/week, the marginal lean mass gain flattens while E2 and hematocrit costs climb steeply — the data is explicit on this:
Changes in fat-free mass, muscle size, and strength were dependent on the administered testosterone dose, with few adverse events reported within the range studied. — Bhasin 2001, Am J Physiol Endocrinol Metab
If you want more growth past 600 mg, the answer is adding a second compound (nandrolone, primo, mast, EQ), not pushing T higher.
Ester Comparison & Injection Cadence#
| Ester | Half-life | Cadence | Notes |
|---|---|---|---|
| Propionate | ~0.8 d | EOD or E3D | Shorter PCT wait (10–14 d), pip is common, good for prep |
| Enanthate | ~4.5 d | Twice weekly | Community default, widely available |
| Cypionate | ~5–8 d | Twice weekly | Interchangeable with enan; US staple |
| Sustanon 250 | Mixed | Twice weekly minimum | The prop fraction needs frequent dosing despite marketing |
| Undecanoate (IM) | ~18–24 d | q10–14 weeks | Clinical TRT tool, rare in physique use |
Once-weekly dosing of long esters is obsolete. It produces a peak/trough swing that manifests as mid-week E2 symptoms and end-of-week flatness. Twice-weekly Mon/Thu (or Sun/Wed) is the standard. EOD is only necessary for propionate.
Route: SC vs IM#
Subcutaneous injection with an insulin pin (29–31g, 1/2") into lower belly fat is now the dominant route for TRT and low-to-mid blasts. It produces equal AUC with a flatter peak, less scar tissue, and lower hematocrit pressure than IM:
Serum testosterone concentrations were similar, and subcutaneous administration was well tolerated and preferred by the majority of subjects. — Spratt 2017, JCEM
Above ~400 mg/week, total volume starts to favor IM (ventroglute, delt, quad) simply because SC gets uncomfortable past ~1 mL per site. Mix and match.
Onset Timing#
- Propionate: noticeable libido/aggression shift within 3–5 days; strength by week 2.
- Enanthate/Cypionate: stable blood levels by week 4–5 (five half-lives to saturation); most users describe "the switch flipping" in week 3–4. Don't frontload and don't panic in week 2 when nothing is happening.
- Loading: no meaningful benefit. A frontload of 2× your weekly dose in week 1 shortens saturation time by ~1 week and isn't worth the E2 spike.
On-Cycle Bloodwork Cadence#
Non-negotiable minimum panel, run at these intervals:
| Timing | Panel |
|---|---|
| Baseline (2–4 wks pre-cycle) | Total T, free T, E2 (LC-MS sensitive), SHBG, CBC, CMP, lipids, PSA if >40 |
| Week 6–8 on-cycle | Total T, E2 sensitive, CBC (watch HCT), lipids, BP log |
| Week 12–14 on-cycle | Same, plus CMP if running orals |
| 4 weeks post-PCT | Total T, free T, LH, FSH, E2, CBC |
E2 must be the LC-MS "sensitive" assay — the standard immunoassay is useless in men on cycle and will mislead you into chasing numbers that don't exist. Dose anastrozole to symptoms and sensitive labs, never prophylactically.
HCT is the single most important on-cycle number. Above 54% you need to donate blood before you continue. SC injection and twice-weekly dosing both help keep it down.
Tapering & PCT Transition#
Injectable T is not tapered — you run your last pin and wait for levels to clear.
- Short esters (prop): start PCT 10–14 days after last injection.
- Long esters (enan/cyp): start PCT 14–18 days after last injection.
- Undecanoate: start PCT 4–6 weeks after last injection.
Standard SERM PCT:
| Week | Nolvadex | Clomid (optional) |
|---|---|---|
| 1 | 40 mg/day | 50 mg/day |
| 2 | 40 mg/day | 50 mg/day |
| 3 | 20 mg/day | 25 mg/day |
| 4 | 20 mg/day | 25 mg/day |
If you didn't run HCG on cycle, front-load 1500–2500 IU/week of HCG for 2–3 weeks before starting SERMs to wake the testes up. Running HCG at 250–500 IU twice weekly throughout the cycle is the cleaner approach and makes PCT dramatically smoother.
Cardiovascular Safety Window#
For TRT-range dosing, the data is now reassuring:
Testosterone-replacement therapy did not cause a significant increase in the incidence of major adverse cardiac events in men with hypogonadism over a median of 22 months. — Lincoff 2023, NEJM (TRAVERSE)
This finding does not extend to 500+ mg/week blasts, and it does not cover a decade of year-round cruising. The practical implication: your HCT, BP, and lipids are the dials that actually matter, and they respond to dose. Keep cycles bounded at 12–16 weeks, cruise at genuine TRT range (not 350 mg), and treat hypertension and dyslipidemia before they compound.
Run the protocol, run the bloodwork, respect the back end. Testosterone is the most predictable compound in the toolkit when you do.
Body Transformation Preview
Lean Mass Gain
11.2 lbs
8.4–14.0 lbs range
Fat Loss
2.2 lbs
1.7–2.8 lbs range
Lean Gain by Week
Risks & mistakes
Common (most users)#
- Water retention / bloat — estrogenic, shows up first in the face and midsection. Mitigation: keep sodium reasonable, stay hydrated, don't panic-dose an AI. Usually self-resolves as E2 equilibrates 3–4 weeks in. If it's genuinely uncomfortable, anastrozole 0.25 mg E3D — not daily.
- Acne / oily skin — back, shoulders, chest most commonly. Mitigation: benzoyl peroxide wash, salicylic acid, nizoral 2× weekly. Isotretinoin at low dose (10–20 mg/day) is the community nuclear option for persistent cases.
- Increased libido and aggression — usually welcome, occasionally disruptive. Mitigation: awareness. If it tips into genuine irritability, check E2 (both directions crash mood) and consider splitting doses more evenly.
- Nipple sensitivity / mild puffiness — early estrogenic signal. Mitigation: nolvadex 10–20 mg/day for 5–7 days knocks it down fast. Don't reach for anastrozole first; SERMs at the breast tissue are the precise tool.
- Injection site soreness (PIP) — ester- and carrier-dependent; propionate and high-BA oils are the main offenders. Mitigation: warm the oil, use 25g or finer, inject slowly, rotate SC/IM sites. Switching to SC with an insulin pin in the belly eliminates PIP for most users.
- Sleep disruption / night sweats — often an E2 issue, sometimes HCT creeping up. Mitigation: bloodwork before blaming the dose. Twice-weekly SC dosing produces flatter peaks than weekly IM.
- Mild BP rise — get a home cuff. Mitigation: cardio 3×/week, telmisartan 20–40 mg if it sits above 135/85, sodium and sleep hygiene.
"Changes in fat-free mass, muscle size, and strength were dependent on the administered testosterone dose, with few adverse events reported within the range studied." — Bhasin et al., Am J Physiol Endocrinol Metab (2001)
Uncommon (dose-dependent or individual)#
- Rising hematocrit — the most important on-cycle monitor. HCT >52% is a flag, >54% is an act-now threshold. Mitigation: donate blood every 8–12 weeks, switch from IM once-weekly to SC twice-weekly (flatter peaks = lower HCT), drop the dose. Pull CBC every 8–12 weeks on any blast.
- Gynecomastia — glandular, not just puffy. If caught early (itchy/tender lump), nolvadex 20 mg/day for 2–4 weeks usually resolves it. Established glandular tissue needs raloxifene 60 mg/day for 6–8 weeks or surgical excision.
- Accelerated MPB — only in the genetically predisposed. Mitigation: topical finasteride + minoxidil, add oral finasteride 1 mg/day if you're willing to accept mild DHT suppression. Don't start a blast without a hair strategy already in place if you have family history.
- Lipid shifts — LDL up, HDL down. Mitigation: cardio, citrus bergamot 1000 mg/day, omega-3s, keep saturated fat moderate. Pull a lipid panel at week 8; if LDL clears 160 or ApoB clears 100, reassess the dose.
- Mood elevation / irritability — a minority of users are outliers here.
"Testosterone administration was associated with an increase in manic scores in a minority of susceptible individuals." — Pope et al., Arch Gen Psychiatry (2000)
- Sleep apnea worsening — T can aggravate AHI, especially in heavier users. Mitigation: if you snore heavily, wake unrefreshed, or have morning headaches, get a home sleep study before blasting.
- BPH / urinary flow changes — uncommon before 40, but possible. PSA baseline is worth pulling once you're past 35.
Rare but serious#
- Thromboembolic events (DVT, PE, stroke) — driven almost entirely by unchecked hematocrit + hypertension. Warning signs: unilateral calf swelling, chest pain, sudden shortness of breath, visual disturbances. Stop and get to an ER. This is the actual pathway people get hurt on — not "test bad for heart."
- Cardiac remodeling (LV hypertrophy, reduced ejection fraction) — a long-term risk of chronic high-dose use, not TRT.
"Testosterone-replacement therapy did not cause a significant increase in the incidence of major adverse cardiac events in men with hypogonadism over a median of 22 months." — Lincoff et al., NEJM (2023)
TRAVERSE is reassuring for replacement-range dosing. It does not extend to multi-year supraphysiologic blasts — budget an echo every few years if you're a lifetime blaster.
- Severe hepatotoxicity — essentially a non-issue for injectable T esters. This is an oral c17-aa concern, not a Test E concern.
- Prolonged azoospermia / primary hypogonadism — the realistic worst case for a young user who cycles without HCG and skips PCT. Recovery can take 6–24 months; occasionally permanent. Warning sign: no morning wood + flat mood + failed PCT bloodwork at 8 weeks post. Restart protocol (HCG + SERMs + hMG) with an endocrinologist familiar with AAS.
- Psychiatric decompensation — manic episodes, aggression spiraling into legal trouble. Rare but real. If you or the people around you notice a genuine personality change, stop and reassess.
Hard contraindications#
- Active or history of prostate cancer or male breast cancer — do not run T.
- Untreated polycythemia (HCT >54%) — fix it first; phlebotomy or drop the dose before continuing.
- Untreated hypertension or dyslipidemia — get BP under 130/80 and ApoB in line before a blast, not during.
- Untreated severe sleep apnea — T worsens AHI; CPAP compliance first.
- Active pursuit of conception in the next 12–24 months — injectable T causes azoospermia. If you need fertility preserved, don't cycle, or run HCG 500 IU EOD + consider low-dose FSH throughout with a fertility-aware provider.
- Severe heart failure — fluid retention alone is disqualifying.
- Pregnancy — AAS exposure in utero causes fetal virilization. Women who are or could become pregnant do not touch testosterone, period.
Gender and PCT considerations#
Women: male-range testosterone doses cause partly irreversible virilization — voice deepening and clitoromegaly do not reverse after cessation. Female physique use, if undertaken at all, is limited to 25–50 mg/week propionate for short blocks, and most women should use oxandrolone or primobolan instead. Therapeutic female dosing for libido is 1–5 mg/day transdermal cream, an order of magnitude below male TRT.
PCT: required after any blast unless you're cruising. Wait 2 weeks after last propionate pin, 3 weeks after enanthate/cypionate, 5+ weeks after undecanoate. Standard protocol: nolvadex 40/40/20/20 mg/day ± clomid 50/50/25/25 mg/day over 4 weeks. If you skipped HCG on-cycle, run HCG 1500–2500 IU/week for 2–3 weeks first to wake up the Leydig cells before hitting the SERMs. Pull full hormonal bloodwork 4 weeks after PCT ends — total T, free T, LH, FSH, E2, SHBG. If LH and FSH aren't back on the board by then, extend or escalate.
Stack & combine
Multipliers applied when these compounds run together. Values > 1 indicate a bonus on that axis. Tap a partner to expand the mechanism.
| Partner | Type | Lean | Fat loss | Recovery |
|---|---|---|---|---|
| synergistic | ×1.08 | ×1.02 | ×1.22 | |
| synergistic | ×1.18 | ×1.05 | ×1.12 | |
| synergistic | ×1.15 | ×1.00 | ×1.18 | |
| synergistic | ×1.15 | ×1.05 | ×1.12 | |
| synergistic | ×1.15 | ×1.10 | ×1.08 | |
| synergistic | ×1.15 | ×1.08 | ×1.10 | |
| synergistic | ×1.15 | ×1.08 | ×1.12 | |
| synergistic | ×1.10 | ×1.15 | ×1.07 | |
| synergistic | ×1.10 | ×1.03 | ×1.15 | |
| synergistic | ×1.12 | ×1.10 | ×1.08 | |
| synergistic | ×1.07 | ×1.00 | ×1.09 |
Featured in stacks1 curated protocol include Testosterone
FAQ — Testosterone
Research & citations
5 studies cited on this page.
Conclusion
Testosterone is the foundation of nearly every bodybuilding and looksmaxxing protocol — straightforward to use, incredibly effective, and fully mapped in both clinical and community literature.
Key takeaways:
- Standard first-cycle dose: 400–500 mg/week (Test E or C), split into two SC or IM injections
- Cycle length: 12–16 weeks, with PCT mandatory starting 2–3 weeks after last pin
- Twice-weekly dosing (not once) keeps estrogen and hematocrit in check and sides minimal
- SubQ injection is now community-preferred for smoother PK and less scar tissue (Spratt 2017)
- Serious lean mass and strength gains are robust, predictable, and dose-dependent (Bhasin 1996/2001, Bhasin 2001)
- Stack mild AIs as-needed for high-E2 symptoms, and run HCG on-cycle to preserve testicular function
- Expect full shutdown of your natural production — always plan your PCT
If you're looking for a proven mass builder, first-cycle anchor, or long-term cruise base, testosterone is as trustworthy and versatile as it gets — just respect the ancillaries, bloodwork, and recovery windows, and you'll pin up with confidence.